CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

BackgroundEarly high-efficacy treatment for people with relapsing multiple sclerosis (pwRMS) may provide better long-term outcomes compared with the escalation strategy. In this study, we present an analysis of treatment success and safety from the CONFIDENCE study in a real-world cohort of pwRMS tr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Mathias Buttmann, Martin S. Weber, Sven G. Meuth, Sandra Blümich, Stefanie Hieke-Schulz, Petra Dirks, Julius C. Eggebrecht, Tjalf Ziemssen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-05-01
Saila:	Frontiers in Neurology
Gaiak:	Relapsing multiple sclerosis humanized monoclonal anti-CD20 antibody neurodegenerative diseases non-interventional study (NIS) ocrelizumab real-world cohort
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1564327/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!